Literature DB >> 24690552

Histological and biochemical analysis of DNA damage after BNCT in rat model.

Mitsuko Masutani1, Diaz Baiseitov2, Tasuku Itoh3, Takahisa Hirai4, Kulzhan Berikkhanova2, Yasufumi Murakami5, Zhaxybay Zhumadilov2, Yoshio Imahori6, Masaharu Hoshi7, Jun Itami8.   

Abstract

To understand the mechanism of tumor cell death induced by boron neutron capture therapy (BNCT) and to optimize BNCT condition, we used rat tumor graft models and histological and biochemical analyses were carried out focusing on DNA damage response. Rat lymphosarcoma cells were grafted subcutaneously into male Wister rats. The rats with developed tumors were then treated with neutron beam irradiation 45min after injection of 330mg/kg bodyweight boronophenylalanine ((10)BPA) (+BPA) or saline control (-BPA). BNCT was carried out in the National Nuclear Center of the Republic of Kazakhstan (neutron flux: 1×10(9)nvt/s, fluence: 6×10(11)nvt) with the presence of background γ-irradiation of 33Gy. 6 and 20h after BNCT treatment, tumors were resected, fixed and subjected to immunohistochemistry and biochemical analyses. Immunostaining of nuclei showed that double strand break (DSB) marker gamma H2AX staining was high in 20h/+BPA sample but not in 20h/-BPA samples. Poly(ADP-ribose), DSB and single strand break markers of DNA, also demonstrated this tendency. These two markers were observed at low levels in unirradiated tissues or 6h after BNCT either under -BPA and +BPA conditions. HMGB1 level increased in 6h/+BPA but not in 6h/-BPA or 20h/+BPA samples. The persistent staining of γH2AX and poly(ADP-ribose) in +BPA group suggests accumulated DSB damage after BNCT. The early HMGB1 upregulation and γH2AX and poly(ADP-ribose) observed later might be the markers for monitoring the DNA damage induced by BNCT.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BNCT; BPA; DNA damage response; HMGB1; PAR; γH2AX

Mesh:

Substances:

Year:  2014        PMID: 24690552     DOI: 10.1016/j.apradiso.2014.03.003

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  3 in total

Review 1.  Clinical Viability of Boron Neutron Capture Therapy for Personalized Radiation Treatment.

Authors:  Dominika Skwierawska; José Antonio López-Valverde; Marcin Balcerzyk; Antonio Leal
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

Review 2.  Boron neutron capture therapy: Current status and future perspectives.

Authors:  Mayya Alexandrovna Dymova; Sergey Yurjevich Taskaev; Vladimir Alexandrovich Richter; Elena Vladimirovna Kuligina
Journal:  Cancer Commun (Lond)       Date:  2020-08-17

3.  Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture Therapy.

Authors:  Shoji Imamichi; Lichao Chen; Tasuku Ito; Ying Tong; Takae Onodera; Yuka Sasaki; Satoshi Nakamura; PierLuigi Mauri; Yu Sanada; Hiroshi Igaki; Yasufumi Murakami; Minoru Suzuki; Jun Itami; Shinichiro Masunaga; Mitsuko Masutani
Journal:  Biology (Basel)       Date:  2022-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.